Graf Akcie UTHR (United Therapeutics Corp). Diskuze k akciím UTHR. Aktuální informace UTHR.

Základní informace o společnosti United Therapeutics Corp (Akcie UTHR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 8.67B
Hodnota podniku (EV) 7.76B
Tržby 1.591B
EBITDA 493.6M
Zisk 470.9M
Růst v tržbách Q/Q 23.34 %
Růst v tržbách Y/Y 11.16 %
P/E (Cena vůči ziskům) 17.77
Forward P/E 4.18
EV/Sales 4.88
EV/EBITDA 15.73
EV/EBIT 12.91
PEG 7.80
Price/Sales 5.45
P/FCF 15.42
Price/Book 2.55
Účetní hodnota na akcii 73.45
Hotovost na akcii 39.70
FCF vůči ceně 6.49 %
Počet zaměstnanců 950
Tržba na zaměstnance 1674000
Profit margin 34.71 %
Operating margin 27.90 %
Gross margin 92.71 %
EBIT margin 37.81 %
EBITDA margin 31.03 %
EPS - Zisk na akcii 10.56
EPS - Kvartální růst 51.45 %
EPS - Očekávaný růst příští rok -7.29 %
Return on assets 10.17 %
Return on equity 13.69 %
ROIC 15.53 %
ROCE 13.27 %
Dluhy/Equity 0.36
Čistý dluh/EBITDA -7.93
Current ratio 7.44
Quick Ratio 7.15
Volatilita 2.92
Beta 0.53
RSI 39.18
Cílová cena analytiků 155
Známka akcie (dle analytiků) 2.00
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 44.923M
Procento shortovaných akcií 5.60 %
Short ratio 8.18 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1999
Země United States

Finanční výsledky akcie UTHR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,483.3$1,448.8$1,627.8$1,725.3$1,598.8$1,465.8
Cost Of Goods Sold$108.1$117.6$198.7$105.7$72.7$69
Gross Profit$1,375.2$1,331.2$1,429.1$1,619.6$1,526.1$1,396.8
Research And Development Expenses$357.7$1,182.6$357.9$264.6$147.6$245.1
SG&A Expenses$423.9$336.2$265.8$330.1$316.8$452.7
Other Operating Income Or Expenses---$-210--
Operating Expenses$889.7$1,636.4$822.4$910.4$537.1$766.8
Operating Income$593.6$-187.6$805.4$814.9$1,061.7$699
Total Non-Operating Income/Expense$45.3$22.6$-46.5$-45.4$-1.5$345.4
Pre-Tax Income$638.9$-165$758.9$769.5$1,060.2$1,044.4
Income Taxes$124.1$-60.5$169.7$351.6$346.5$392.8
Income After Taxes$514.8$-104.5$589.2$417.9$713.7$651.6
Other Income------
Income From Continuous Operations$514.8$-104.5$589.2$417.9$713.7$651.6
Income From Discontinued Operations------
Net Income$514.8$-104.5$589.2$417.9$713.7$651.6
EBITDA$643.5$-141.7$841.3$845.9$1,093.3$731.9
EBIT$593.6$-187.6$805.4$814.9$1,061.7$699
Basic Shares Outstanding444444444446
Shares Outstanding454444454751
Basic EPS$11.65$-2.39$13.54$9.50$16.29$14.17
EPS - Earnings Per Share$11.54$-2.39$13.39$9.31$15.25$12.72
# 2020 2019 2018 2017 2016 2015
Current Ratio6.70344.0276.39193.25594.28512.8938
Long-term Debt / Capital0.19070.17750.08230.1063--
Debt/Equity Ratio0.23560.30570.08970.1189--
Gross Margin92.712291.882987.793393.873595.452895.2927
Operating Margin40.0189-12.948649.477847.232466.406147.6873
EBIT Margin40.0189-12.948649.477847.232466.406147.6873
EBITDA Margin43.383-9.780551.683349.029268.382549.9318
Pre-Tax Profit Margin43.0729-11.388746.621244.600966.312271.2512
Net Profit Margin34.7064-7.212936.196124.221944.639744.4535
Asset Turnover0.32140.37020.47860.59920.68750.671
Inventory Turnover Ratio1.24971.25911.96730.97960.7270.8487
Receiveable Turnover9.42389.56949.26475.80717.45367.6027
Days Sales In Receivables38.731938.142639.39762.853748.969548.0093
ROE - Return On Equity15.1626-3.758521.128919.88338.551341.0173
Return On Tangible Equity15.9031-3.985422.507520.323939.268241.7639
ROA - Return On Assets11.1549-2.670317.324314.513430.688929.8297
ROI - Return On Investment12.2712-3.091419.390517.769438.551341.0173
Book Value Per Share76.284663.356563.976348.607843.087634.7152
Operating Cash Flow Per Share21.6609-22.40787.1296-3.19086.27550.9212
Free Cash Flow Per Share22.2961-20.12794.6759-4.11616.43630.8231